United Kingdom

People: Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

17 Aug 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lewis, Michael 

Dr. Michael E. Lewis is the Chief Scientific Advisor at Cara Therapeutics, Inc. Previously, he has co-founded Cephalon, Inc. and served as Director of Pharmacology and Senior Director of Scientific Affairs. He also co-founded and served as Chief Scientific Advisor to Adolor Corporation and also participated on their analgesics development team and assisted in pre-initial public offering (IPO) financing and corporate partnering presentations. He was co-founded Arena Pharmaceuticals, and served as a pre-IPO Director and Chief Scientific Advisor to Arena. He is a Director of PolyMedix, Inc., a privately held biotechnology company that is developing antimicrobial agents based on a novel computational chemistry platform.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --